Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

DuPont focuses on development of MMP inhibitors selective for TNF production

Dec. 15, 1999

Hoechst DMARD now in U.K. pharmacies

Dec. 15, 1999

Cypress Bioscience and Medexus enter agreement for Prosorba Column in Canada

Dec. 13, 1999

Potent and selective caspase 1 (ICE) inhibitors codeveloped at Warner-Lambert and BASF

Dec. 10, 1999

COX-2 inhibitors: pros and cons debated in current literature

Dec. 7, 1999

p38 MAP kinase inhibitors described by Roche for inflammatory disorders

Dec. 6, 1999

Promising results seen in phase II/III lupus clinical trial

Dec. 3, 1999

First murine (and human) CCR1 receptor antagonist reported by Banyu at Japanese meeting

Dec. 2, 1999

6-Nitroquinazolines with dual TNF-alpha production/T-cell proliferation-suppressive effects

Dec. 2, 1999

Fused thiophenes from Ono inhibit IL-6 and/or IL-12 production

Dec. 2, 1999

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...